logo

High Flow Needle Sets Market Size (2024 - 2029)

The high flow needle sets market is anticipated to experience growth driven by the increasing prevalence of diabetes, particularly among the aging baby boomer population. These needle sets are essential for administering more viscous drugs, and their market size is further influenced by new product launches that emphasize safety and precision. The preference for high flow needle technology over conventional options among healthcare personnel, due to its efficacy and design, also contributes to market expansion. However, the market's growth may be hindered by the limited adoption of these needle sets in developing regions.

Home Market Analysis Healthcare Research Medical Devices Research Medical Supplies Research Medical Consumables Research Surgical Supplies Research High Flow Needle Sets Market Market Size

Market Size of High Flow Needle Sets Industry

cagr
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 6.60 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

High Flow Needle Sets Market Analysis

The global high flow needle sets market is expected to grow at a CAGR of 6.6% over the forecast period. Rising prevalence of diabetes owing to growing number of baby boomers is a key factor for market growth. High flow needles are used when there is a need of administering more viscous drugs into the body. According to the International Diabetes Federation, approximately 463 million adults were living with diabetes in 2019 and this number is expected to reach 700 million in 2045 which will further bolster the overall growth.

In addition, new product launches by major companies across the globe to introduce technology with maximum safety and precision is expected to contribute to the market expansion. For instance, RMS medical products received FDA 510(k) clearance for high-flo super26 subcutaneous needle sets which allows subcutaneous infusion of medications in the home, hospital, or ambulatory settings to facilitate high flow rates. Factors such as the safe delivery and efficacy of subcutaneous therapies, promote compliance, and prompt use design were favorable with the majority of health care personnel preferring high flow needle technology as compared to conventional needles.

Certain treatment regimens are associated with pain and anxiety where various psychological and physical factors trigger the pain receptors of the brain. For instance, there is a close association of pain and anxiety with dental injection during dental procedures. These factors boost the high flow needles set market over forecast period. However, low adaptation of the high flow needle sets in under developing regions may restrict the market.

High Flow Needle Sets Industry Segmentation

High flow needle sets are designed to ensure the safety and comfort of users. The high flow needles are used when there is more viscous drugs needs to administer into the body. It enables faster flow and smother insertion of drugs by reducing the pain and gives more comfort as compared to traditional needles. The high flow needle sets market is segmented by volume capacity, raw material, end use and geography.

By Volume Capacity
Less than 10ml
10-100ml
More than 100ml
By Raw Material
Stainless Steel
Polycarbonate
By End Use
Hospitals
Ambulatory Surgical Centers
Diagnostic Center
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

High Flow Needle Sets Market Size Summary

The high flow needle sets market is poised for significant growth, driven by the increasing prevalence of diabetes and the aging baby boomer population. These needle sets are essential for administering more viscous drugs, and their adoption is bolstered by new product launches that emphasize safety and precision. The market is experiencing a shift towards high flow needle technology due to its advantages in delivering subcutaneous therapies effectively, which are preferred by healthcare professionals over conventional needles. Despite these advancements, the market faces challenges in underdeveloped regions where adoption rates are low. Hospitals remain the largest end-use segment, benefiting from high patient turnover and the need for efficient surgical procedures, while diagnostic centers are expected to grow due to the rising diagnosis of chronic disorders.

Regionally, North America leads the market, supported by major players and collaborative efforts to enhance research and development. The increasing prevalence of chronic disorders among diverse age groups in this region is driving demand for high flow needle sets. Meanwhile, the Asia-Pacific region is anticipated to experience the fastest growth, fueled by economic development and investments in healthcare infrastructure. The region's emergence as a medical tourism destination further boosts market demand. The competitive landscape is characterized by efforts from research institutes and medical device manufacturers to innovate and expand market reach through strategic partnerships. Key players in the market include AmDel, B. Braun Medical Inc., KORU Medical Systems, and Thermo Fisher Scientific, among others.

Explore More

High Flow Needle Sets Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Chronic Diseases

      2. 1.2.2 Introduction of the Novel Drug Delivery System

      3. 1.2.3 Extensive R&D to Introduce Needle Technology with Mazimum Safety

    3. 1.3 Market Restraints

      1. 1.3.1 Low Adaptation of the High Flow Needle Sets

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Volume Capacity

      1. 2.1.1 Less than 10ml

      2. 2.1.2 10-100ml

      3. 2.1.3 More than 100ml

    2. 2.2 By Raw Material

      1. 2.2.1 Stainless Steel

      2. 2.2.2 Polycarbonate

    3. 2.3 By End Use

      1. 2.3.1 Hospitals

      2. 2.3.2 Ambulatory Surgical Centers

      3. 2.3.3 Diagnostic Center

      4. 2.3.4 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle-East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle-East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

High Flow Needle Sets Market Size FAQs

The High Flow Needle Sets Market is projected to register a CAGR of 6.60% during the forecast period (2024-2029)

B. Braun Medical Inc, KORU Medical Systems , Medline Industries, Inc, Smiths Group plc and Thermo Fisher Scientific are the major companies operating in the High Flow Needle Sets Market.

High Flow Needle Sets Report Snapshots

High Flow Needle Sets Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)